Search Within

Radiology, Department of

  1. "Michael Morris"
Formats
  1. Journal Article (86)
  2. Meeting Abstract (66)
  3. Review (6)
  4. Book Section (3)
  5. Guidelines (1)
Groups
  1. Department of Medicine (162)
  2. Genitourinary Oncology Service (162)
  3. Solid Tumor Oncology Division (162)
  4. Molecular Imaging and Therapy Service (134)
  5. GSK Faculty (120)
  6. Molecular Pharmacology and Chemistry Program Faculty (97)

More Groups

People
  1. Michael Morris (162)
  2. Howard Scher (109)
  3. Steven Larson (93)
  4. Neeta Pandit-Taskar (45)
  5. Susan Slovin (36)
  6. Dana Rathkopf (31)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (8)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (52)
  2. Journal of Nuclear Medicine (30)
  3. Clinical Cancer Research (10)
  4. Cancer (5)
  5. Annals of Oncology (4)
  6. Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (54)
  2. Society of Nuclear Medicine (30)
  3. American Association for Cancer Research (15)
  4. Springer (11)
  5. Wiley Blackwell (9)
  6. Elsevier Inc. (7)

More Publishers

Results (162)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel predictive model using changes in clinical and serum biomarkers and automated quantitative imaging for mCRPC patients treated with AR-directed therapy
    Meeting Abstract

    Morris, M. J.; Flynn, J.; Zhao, B.; Anand, A.; Sjöstrand, K.; Larson, S. M.; Scher, H. I.; Regazzi, A. M.; Borzillo, G. V.; Park, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical, imaging, and technical factors associated with successful genomic profiling of bone biopsy tissue in prostate cancer
    Journal Article

    Ridouani, F.; Vargas, H. A.; Holzwanger, D. J.; Schöder, H.; Waters, E.; Petre, E. N.; Martin, A.; Satagopan, J.; Gonen, M.; Autio, K. A.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Validation of automated bone scan index as a progression endpoint in two phase III studies of metastatic castration resistant prostate cancer (mCRPC) patients
    Meeting Abstract

    Knezevic, A.; Heller, G.; Sjöstrand, K.; Anand, A.; Borzillo, G.; Larson, S.; Morris, M. J.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Prostate cancer working group 4 (PCWG4) preliminary criteria using serial PSMA PET/CT for response evaluation: Analysis from the PRINCE trial
    Meeting Abstract

    Hofman, M. S.; Gafita, A.; Bressel, M.; Alipour, R.; Levy, S.; Emmett, L.; Ravi Kumar, A. S.; Hamid, A. A.; Buteau, J. P.; Kuo, P. H.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • A phase 0 study to assess the biodistribution and pharmacokinetics of a radiolabeled antibody targeting human kallikrein 2 in participants with metastatic castration-resistant prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Chetty, D.; Max, S.; Wanik, D.; Ilovich, O.; Russell, M.; Nyima, T.; Divgi, C. R.; Yu, M.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Case study #8: Alpha-therapy with radium-223 dichloride for metastatic castration-resistant prostate cancer
    Book Section

    Pasquini, L.; Morris, M. J.; Bodei, L.
    In Bodei, L.; Lewis, J. S.; Zeglis, B. M. (Eds.) Radiopharmaceutical Therapy (2023)

    Fulltext@MSK | Save
  • A phase 1, open-label, dose-ascending study to evaluate the safety and tolerability of the therapeutic radiopharmaceutical (131)I-MIP-1095 for the treatment of metastatic castration-resistant prostate cancer
    Journal Article

    Laccetti, A. L.; Bodei, L.; O'Donoghue, J. A.; Weber, W. A.; Morris, M. J.
    Clinical Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • A pilot study of stereotactic body radiotherapy and (177)Lu-PSMA-617 for oligometastatic hormone sensitive prostate cancer
    Meeting Abstract

    Imber, B. S.; Bodei, L.; Humm, J.; Ionescu, A.; Wu, W.; Grkovski, M.; O'Donoghue, J.; Reddy, R. P.; Rimner, A.; Shasha, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • SNMMI consensus statement on patient selection and appropriate use of (177)Lu-PSMA-617 radionuclide therapy
    Guidelines

    Hope, T. A.; Antonarakis, E. S.; Bodei, L.; Calais, J.; Iravani, A.; Jacene, H.; Koo, P. J.; Morgans, A. K.; Osborne, J. R.; Tagawa, S. T.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save